Andy Lane

@lane_andy

Professor of Medicine, Harvard Medical School; Chief, Division of Hematologic Neoplasia, Dana-Farber Cancer Institute

lanelab.dana-farber.org Joined January 2011

311 Following 2.6K Followers 1.5K Posts

Latest posts 5

Pivekimab sunirine and the evolving treatment of blastic plasmacytoid dendritic cell neoplasm ashpublications.org/blood/article-…

ashpublications.org Pivekimab sunirine and the evolving treatment of blastic plasmacytoid dendritic cell neoplasm Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy characterized by leukemic blasts with frequent cutaneous involvement

Andy Lane @lane_andy Nov 4

So much exciting science to read this morning: #ASH26 Abstracts are available hematology.org/meetings/annua…

Andy Lane @lane_andy Nov 2

Building on Tagraxofusp: Triplet Therapy Improves Outcomes in Patients With BPDCN ashpublications.org/ashclinicalnew…

Andy Lane @lane_andy Oct 30

Amazing retrospective from Jim Griffin and Rich Stone on the development of FLT3 inhibitors for AML, at the Dana-Farber Dept of Medical Oncology faculty retreat.

Andy Lane @lane_andy Oct 29

Very happy to have participated in this podcast with @BloodPortfolio about our new paper on the phase 2 trial of TAG-AZA-VEN for #BPDCN bloodpodcast.transistor.fm/episodes/xxx

bloodpodcast.transistor.fm Blood Podcast | Triple threat for BPDCN and Human Milk Oligosaccharides after HSCT In this week's episode, Blood editor Dr. Laurie Sehn interviews Dr. Andrew Lane from the Dana-Farber Cancer Institute and Dr. Pooja Khandelwal from the Cincinnati Children's Hospital Medical Center...